How were Leucadia National's earnings last quarter?

Leucadia National Corp (NYSE:LUK) issued its quarterly earnings results on Thursday, April, 26th. The conglomerate reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.32 by $0.02. The conglomerate earned $2.68 billion during the quarter, compared to the consensus estimate of $2.47 billion. Leucadia National's revenue for the quarter was down 6.5% on a year-over-year basis. During the same period last year, the company earned $0.75 earnings per share.

Is Leucadia National a good dividend stock?

Leucadia National (NYSE:LUK) pays an annual dividend of $0.40 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 21.74%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for LUK .

What other stocks do shareholders of Leucadia National own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Leucadia National investors own include Gilead Sciences (GILD) , General Electric (GE) , International Business Machines (IBM) , Schlumberger (SLB) , Allergan (AGN) , Bausch Health Companies (BHC) , Blackstone (BX) , Ford Motor (F) , The Goldman Sachs Group (GS) and Intel (INTC) .

NYSE:LUK

Leucadia National (LUK) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free LUK Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $23.27
▼
$23.49
50-Day Range: N/A
52-Week Range: $21.61
▼
$28.30

Volume: 1.82 million shs
Average Volume: 3.06 million shs
Market Capitalization: N/A

P/E Ratio: 12.76
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Leucadia National alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Leucadia National Stock (NYSE:LUK)

Jefferies Financial Group, Inc. is a holding company, which engages in the provision of financial services. It operates through the following segments: Investment Banking, Capital Markets, and Asset Management; Merchant Banking; and Corporate segments. The Investment Banking, Capital Markets, and Asset Management segment consists of investments in Jefferies Group. The Merchant Banking segment includes various merchant banking businesses and investments, primarily including Linkem, Vitesse Energy Finance and JETX Energy, real estate, Idaho Timber, and FXCM. The Corporate segment pertains to cash and cash equivalents, financial instruments owned, and deferred tax asset of the firm. The company was founded in 1968 and is headquartered in New York, NY.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

LUK Stock News Headlines

November 13, 2023 | thestreet.com

Sage Kelly’s Escapades Blunt Jefferies Year-End Banker Bonuses

September 5, 2023 | thestreet.com

These Funds Use Options to Smooth Market's Bumps

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

May 19, 2023 | fool.com

Who Is Bill Ackman?

March 23, 2023 | thestreet.com

Juniper Networks, Staples: Ratings Changes

January 5, 2023 | forbes.com

Jefferies Financial

September 4, 2022 | thestreet.com

FXCM Stock Sinking Today Following Analyst Downgrade

February 14, 2022 | gurufocus.com

Leucadia National Buys Ranger Oil Corp, Ranger Oil Corp, Ranger Oil Corp, Sells Wheels Up ...

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 3, 2022 | thestreet.com

10 Hated Stocks Loved by Value-Guru Berkowitz

October 26, 2021 | finance.yahoo.com

Leucadia National (JEF): An Off-the-Radar Potential Winner

See More Headlines

Receive LUK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Leucadia National and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 4/26/2018
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Conglomerates
Industry: Meat Packing Plants
Sub-Industry: Multi-Sector Holdings
Current Symbol: NYSE:LUK
CUSIP: 52728810
CIK: 96223
Web: www.leucadia.com
Phone: (212) 460-1900
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 12.76
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Rich Handler
Chief Executive Officer & Director
Brian P. Friedman
President & Director
Teresa S. Gendron
Chief Financial Officer & Vice President
Rocco J. Nittoli
Chief Compliance Officer & Vice President
Michael J. Sharp
Executive Vice President & General Counsel

LUK Stock Analysis - Frequently Asked Questions

How were Leucadia National's earnings last quarter?: Leucadia National Corp (NYSE:LUK) issued its quarterly earnings results on Thursday, April, 26th. The conglomerate reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.32 by $0.02. The conglomerate earned $2.68 billion during the quarter, compared to the consensus estimate of $2.47 billion. Leucadia National's revenue for the quarter was down 6.5% on a year-over-year basis. During the same period last year, the company earned $0.75 earnings per share.
Is Leucadia National a good dividend stock?: Leucadia National (NYSE:LUK) pays an annual dividend of $0.40 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 21.74%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for LUK.
What other stocks do shareholders of Leucadia National own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Leucadia National investors own include Gilead Sciences (GILD), General Electric (GE), International Business Machines (IBM), Schlumberger (SLB), Allergan (AGN), Bausch Health Companies (BHC), Blackstone (BX), Ford Motor (F), The Goldman Sachs Group (GS) and Intel (INTC).

This page (NYSE:LUK) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Leucadia National (LUK) Stock Price, News & Analysis

About Leucadia National Stock (NYSE:LUK)

LUK Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

LUK Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info